Search

Displaying results 9521 - 9530 of 10000 in total
  1. Drug

    Vibozilimod

    go.drugbank.com/drugs/DB21505
    Experimental

    The usage of the INN stem '-imod' in the name indicates that Vibozilimod is a immunomodulator, both stimulant/suppressive and stimulant. Vibozilimod has a monoisotopic molecular weight of 541.23 Da.

  2. Drug

    Zectivimod

    go.drugbank.com/drugs/DB21525
    Experimental

    The usage of the INN stem '-imod' in the name indicates that Zectivimod is a immunomodulator, both stimulant/suppressive and stimulant. Zectivimod has a monoisotopic molecular weight of 527.17 Da.

  3. Drug

    Capeserod

    go.drugbank.com/drugs/DB20267
    Experimental

    The usage of the INN stem '-serod' in the name indicates that Capeserod is a serotonin receptor antagonist and partial agonist. Capeserod has a monoisotopic molecular weight of 456.16 Da.

  4. Drug

    Icanbelimod

    go.drugbank.com/drugs/DB21572
    Experimental

    The usage of the INN stem '-imod' in the name indicates that Icanbelimod is a immunomodulator, both stimulant/suppressive and stimulant. Icanbelimod has a monoisotopic molecular weight of 409.18 Da.

  5. Drug

    MK-0767

    go.drugbank.com/drugs/DB12055
    Investigational

    MK0767 has been used in trials studying the treatment of Dyslipidemia, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2, and Diabetes Mellitus, Type II, among others.

  6. Drug

    Eleclazine

    go.drugbank.com/drugs/DB12394
    Investigational

    Eleclazine has been used in trials studying the treatment of LQT2 Syndrome, Long QT Syndrome, Ischemic Heart Disease, Ventricular Arrhythmia, and Long QT Syndrome Type 3, among others.

  7. Drug

    Gusacitinib

    go.drugbank.com/drugs/DB15670
    Investigational

    Gusacitinib is under investigation in clinical trial NCT02550678 (A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma).

  8. Drug

    Camlipixant

    go.drugbank.com/drugs/DB19217
    Investigational

    Camlipixant is under investigation in clinical trial NCT05600777 (A 24-week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)).

  9. Drug

    Tiaramide

    go.drugbank.com/drugs/DB20499
    Experimental

    Tiaramide is a small molecule drug. Tiaramide has a monoisotopic molecular weight of 355.08 Da.

    Categories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal
  10. Drug

    RO-7293583

    go.drugbank.com/drugs/DB17455
    Investigational

    RO-7293583 is a TYRP1-Targeting CD3 T-Cell Engager.